Adam Bagg

22.4k citations
220 papers · 11.9k · 5 hit papers · h-index 38

Impact in

  • Oncology top 0.1%
    • CAR-T cell therapy research
  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 67
    • Chronic Myeloid Leukemia Treatments 22
    • Chronic Lymphocytic Leukemia Research 56
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 29

Adam Bagg

207 papers receiving 11.7k citations

Adam Bagg's Hit Papers

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma 2015 · 437 citations
4370+7+15Years since publication50010001.5k2.0k2.5k

Peers

Adam Bagg
Comparison fields: 5 of 135
  • Oncology 6.7k
  • Hematology 1.8k
  • Genetics 1.5k
  • Immunology 2.9k
  • Pathology and Forensic Medicine 1.6k
Replace David T. Teachey with:
David T. Teachey United States
Sattva S. Neelapu United States
Partow Kebriaei United States
Mariusz A. Wasik United States
Maryalice Stetler‐Stevenson United States
David L. Porter United States
Stephen J. Schuster United States
Katayoun Rezvani United States
Stephen Gottschalk United States
Cameron J. Turtle United States
Adam Bagg relative to David T. Teachey United States David T. Teachey's profile →
Citations per field
00.5×1.5×1.9×
David T. Teachey · 1×
Citations per year

Countries citing papers authored by Adam Bagg

Since Specialization
Citations

This map shows the geographic impact of Adam Bagg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Bagg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Bagg more than expected).

Fields of papers citing papers by Adam Bagg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Bagg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Bagg. The network helps show where Adam Bagg may publish in the future.

Co-authors

The 25 scholars most cited alongside Adam Bagg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam Bagg Line = papers co-authored together Adam Bagg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
Hit paper breakdown →
20112684
2
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Hit paper breakdown →
20111800
3
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
Hit paper breakdown →
20151329
4
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
Hit paper breakdown →
20031080
5
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Hit paper breakdown →
2015437
6 2003385
7 2003317
8 2016200
9 2007197
10 1993128
11 2015120
12 2003113
13 2011106
14 200796
15 200986
16 199584
17 201683
18 200982
19 200271
20 198671

About Adam Bagg

Adam Bagg is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 220 papers that have together received 11.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (77 papers), Acute Myeloid Leukemia Research (67 papers), Chronic Lymphocytic Leukemia Research (56 papers), Viral-associated cancers and disorders (32 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (29 papers), Chronic Myeloid Leukemia Treatments (22 papers), Acute Lymphoblastic Leukemia research (20 papers) and Eosinophilic Disorders and Syndromes (19 papers). The work is most often cited by research in Oncology (6.7k citations), Hematology (1.8k citations), Genetics (1.5k citations), Immunology (2.9k citations) and Pathology and Forensic Medicine (1.6k citations). Adam Bagg has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Carl H. June, Bruce L. Levine, David L. Porter, Michael Kalos, Stephan A. Grupp, Sharyn I. Katz, Guangping Gao, James M. Wilson, Frank S. Lee and Steven E. Raper. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Modern Pathology, Journal of Molecular Diagnostics and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact